These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 13641422)

  • 21. COEXISTENT PAROXYSMAL NOCTURNAL AND COLD HEMOGLOBINURIA PRECEDED BY APLASTIC ANEMIA: A CASE REPORT AND FAMILY STUDY.
    MENGEL CE; HYMAN BN; O'MALLEY BW; HOWELL DA
    Blood; 1964 Oct; 24():451-7. PubMed ID: 14220787
    [No Abstract]   [Full Text] [Related]  

  • 22. Paroxysmal nocturnal hemoglobinuria: erythrocyte acetylcholinesterase deficit analyzed by immunoassay and fluorescence-activated sorting.
    Brimijoin S; Hammond PI; Petitt RM
    Mayo Clin Proc; 1986 Jul; 61(7):522-9. PubMed ID: 3520169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Fredrick LR; Bernshaw NJ; Wilcox LA; Parker CJ
    J Clin Invest; 1989 Jul; 84(1):7-17. PubMed ID: 2738160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxysmal nocturnal hemoglobinuria. II. Permeability and phosphate turnover in the red blood cells.
    HELLEM AJ; SKAUG OE
    Scand J Clin Lab Invest; 1955; 7(2):121-5. PubMed ID: 13255805
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporation of radioactive choline into normal and PNH-like red blood cells. Effect of acetylcholinesterase inhibitors.
    Falezza GC; Corrocher R; Pennacchioni A; Aprili G; De Sandre G
    Haematologica; 1978 Dec; 63(6):667-74. PubMed ID: 107083
    [No Abstract]   [Full Text] [Related]  

  • 26. THE EFFECT OF SEVERE CHOLINESTERASE INHIBITION ON ERYTHROCYTE SURVIVAL IN MAN.
    GOLDIN A; RUBENSTEIN A; BRADLOW BA
    S Afr J Med Sci; 1964 Jul; 29():37. PubMed ID: 14235200
    [No Abstract]   [Full Text] [Related]  

  • 27. An increased calcium accumulation in ATP-depleted red cells of the patients with paroxysmal nocturnal hemoglobinuria.
    Shimoda M; Yawata Y
    Am J Hematol; 1985 Dec; 20(4):325-35. PubMed ID: 4073008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the cholinergic activity of the blood in patients with paroxysmal nocturnal hemoglobinuria].
    Savina LS; Sokolinskaia RA; Lobanova NA
    Probl Gematol Pereliv Krovi; 1975 Mar; 20(3):40-4. PubMed ID: 1219720
    [No Abstract]   [Full Text] [Related]  

  • 29. [Enzymatic and metabolic activities of erythrocytes in paroxysmal nocturnal hemoglobinuria].
    Ferrone S; Zanella A; Sirchia G
    Acta Vitaminol Enzymol; 1970; 24(6):237-63. PubMed ID: 5537938
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
    Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
    Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biochemical and functional characteristics of erythrocytes in paroxysmal nocturnal hemoglobinuria].
    Andreeva AP; Levina AA; Dmitrieva MG; Kazanets EG; Soboleva SS
    Gematol Transfuziol; 1989 Jul; 34(7):23-6. PubMed ID: 2792714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxysmal nocturnal hemoglobinuria and complement-mediated erythrocyte damage.
    Parker CJ
    Curr Opin Hematol; 1994 Mar; 1(2):151-6. PubMed ID: 9371274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ACETYLCHOLINESTERASE ACTIVITY AND ACID RESISTANCE IN ERYTHROCYTES TREATED WITH DIFFERENT SUBSTANCES].
    PATRASSI G; DESANDRE G; GHIOTTO G
    Verh Dtsch Ges Inn Med; 1964; 70():662-5. PubMed ID: 14294294
    [No Abstract]   [Full Text] [Related]  

  • 34. THE SYNDROME OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    BEAL RW; KRONENBERG H; FIRKIN BG
    Am J Med; 1964 Dec; 37():899-914. PubMed ID: 14246091
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunophenotyping study on the blood cells of the patients with paroxysmal nocturnal hemoglobinuria].
    Chen G; Shao Z; Jia H; Chu Y; Shen D; Zhang Y; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):190-2. PubMed ID: 15622765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the role of red cell membrane peroxidation in paroxysmal nocturnal haemoglobinuria (PNH).
    Paniker NV; Arnold AB; Hartmann RC
    Br J Haematol; 1974 Jan; 26(1):39-47. PubMed ID: 4854457
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation between low erythrocyte acetylcholinesterase activity and membrane lipids in paroxysmal nocturnal haemoglobinuria.
    Siriwittayakorn J; Yuthavong Y
    Br J Haematol; 1979 Mar; 41(3):383-91. PubMed ID: 427042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxysmal nocturnal hemoglobinuria: an historical overview.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: A single-center experience in Saudi Arabia.
    AlGhasham N; Abulkhair Y; Khalil S
    Cytometry B Clin Cytom; 2015; 88(6):389-94. PubMed ID: 26296648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MALATHION POISONING WITH SPECIAL REFERENCE TO THE EFFECT OF CHOLINESTERASE INHIBITION ON ERYTHROCYTE SURVIVAL.
    GOLDIN AR; RUBENSTEIN AH; BRADLOW BA; ELLIOTT GA
    N Engl J Med; 1964 Dec; 271():1289-93. PubMed ID: 14214635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.